Short answer · Medically reviewed summary · Last updated: 2026-05-08
The prevalence of a brain tumor varies significantly by histological type, but primary malignant brain tumors are generally considered rare, with an incidence of approximately 6 to 8 cases per 100,000 people annually. Because "brain tumor" is an umbrella term encompassing over 120 different types of intracranial growths, global prevalence data is complex and often categorized by specific malignancy rather than as a single condition. Is a brain tumor considered a rare disease? While some benign intracranial growths are relatively common, primary malignant brain tumors are classified as rare diseases.
What is the prevalence of Brain Tumor?
Prevalence of Brain Tumor: how many people are affected worldwide, differences by sex and region, with sources.
The prevalence of a brain tumor varies significantly by histological type, but primary malignant brain tumors are generally considered rare, with an incidence of approximately 6 to 8 cases per 100,000 people annually. Because "brain tumor" is an umbrella term encompassing over 120 different types of intracranial growths, global prevalence data is complex and often categorized by specific malignancy rather than as a single condition.
Is a brain tumor considered a rare disease?
While some benign intracranial growths are relatively common, primary malignant brain tumors are classified as rare diseases. According to the Central Brain Tumor Registry of the United States (CBTRUS), the incidence rate for primary malignant brain tumors is roughly 7.2 per 100,000. It is important to note that these figures often exclude metastatic tumors (cancer that has spread to the brain from elsewhere), which are significantly more prevalent than primary brain tumors.
How does age and gender impact brain tumor distribution?
The occurrence of a brain tumor is influenced by both age and biological sex:
- Age of Onset: While pediatric brain tumors are the most common solid tumors in children, the incidence of primary malignant brain tumors generally increases with age, peaking in adults between ages 75–84.
- Gender Differences: Males are generally at a slightly higher risk for primary malignant brain tumors than females. Conversely, certain benign tumors, such as meningiomas, are significantly more frequent in females.
Why is accurate brain tumor data challenging to track?
Estimating the exact number of people living with a brain tumor is difficult due to several factors:
- Diagnostic Complexity: Many slow-growing or benign brain tumors may remain asymptomatic for years, leading to underdiagnosis.
- Reporting Discrepancies: Global registries often struggle to capture data on non-malignant brain tumors, focusing primarily on high-grade malignancies.
- Community Perspectives: Statistics provide a clinical view, but the 56 members of the DiseaseMaps.org community offer a vital, real-world perspective on the lived experience and diagnostic journeys that clinical databases may miss.
Next steps
- Consult a neuro-oncologist to understand the specific subtype and grade of the brain tumor.
- Review clinical trial databases like ClinicalTrials.gov if you are seeking novel treatment options.
- Connect with the 56 members of the DiseaseMaps.org community to share experiences and coping strategies.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.
References
- Central Brain Tumor Registry of the United States (CBTRUS) Statistical Report.
- NIH Genetic and Rare Diseases Information Center (GARD).
- World Health Organization (WHO) Classification of Tumours of the Central Nervous System.
- Orphanet: Portal for rare diseases and orphan drugs.
